peptide melanocortin-5 receptor inhibitor (Akhu Therapeutics)
N/A
Report date: 2025/01/26 16:45:29
Base Information
Drug Namepeptide melanocortin-5 receptor inhibitor (Akhu Therapeutics)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe University Of Arizona
China Registration ClassN/A
Develop Information
Active CompaniesAkhu Therapeutics Inc
Inactive CompaniesTexas A&M University SystemThe University Of Arizona
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A